Biomet’s M2a Magnum hip replacement has been included in the Food and Drug Administration’s (FDA) watch list because of the disturbing number of reported complaints from patients and hundreds of Biomet lawsuits filed in the United States, an online source reveals. A consolidation of M2a Magnum lawsuits took place on October 4, 2012 by the judicial panel of multidistrict litigation headed by Judge Robert Miller, says a report published in dockets.justia.com/docket/indiana/inndce/3:2012md02391/71286/. M2a Magnum is a metal-on-metal hip replacement by Biomet Orthopedics. It used to be the company’s in-demand medical device among its line of products but has recently been receiving negative feedbacks from patients who claimed that its design was defective, causing metal toxicity and early failure.
0 Comments
One of the popular makers for reconstructive medical devices, such as hip replacement implants, is Biomet.M2a-Magnum is a Biomet-produced metal hip replacement that aims to provide absolute range of motion, offering the potential of 160 degrees range of motion.People think that surgery causes the main problem; however, there are some who believed that the implant itself causes problems, reported an article from ehow.com/facts_7670168_biomet-hemiarthroplasty.html.
|